IgA-positive Versus IgA-negative Immune Complex Vasculitis
Retrospective Analysis of Frequency of Systemic Involvement in IgA-positive Cutaneous Immune Complex Vasculitis Versus IgA-negative Cutaneous Immune Complex Vasculitis
1 other identifier
observational
300
1 country
1
Brief Summary
Cutaneous vasculitis due to vascular deposition of large circulating immune complexes is a disease frequently seen by general practitioners and dermatologists. The clinical symptom is palpable purpura with predilection for the lower legs. In some cases vasculitis also affects systemic organs, such as the kidneys and the intestine. When the immune complexes contain immunoglobulin class A (IgA) and when there is systemic involvement, the disease has been referred to as Henoch Schönlein purpura. When there are no signs of systemic involvement, the disease has been referred to as cutaneous leukocytoclastic angiitis. The investigators hypothesize that palpable purpura with predilection for lower legs is a pathognomonic clinical sign for immune complex vasculitis in both IgA vasculitis and IgA-negative vasculitis, but that only the presence of IgA in immune complexes is likely to be associated with systemic involvement and therefore warrants more extensive diagnostic procedures Vice versa the investigators postulate that the presence of IgG or IgM without IgA in immune complexes excludes systemic involvement The investigators also want to investigate to which of the 2 groups patients with palpable purpura and negative immunofluorescence should be assigned.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 18, 2013
CompletedFirst Posted
Study publicly available on registry
March 20, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 2, 2015
November 1, 2015
5.9 years
March 18, 2013
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of systemic involvement in patients with IgA-positive versus patients with non-IgA-positive immune complex vasculitis
10 years
Study Arms (2)
IgA-positive vasculitis
Patients with immune complex vasculitis who show perivascular deposits of IgA
IgA-negative vasculitis
Patients with immune complex vasculitis who show no perivascular deposits of IgA
Eligibility Criteria
All patients of the department of dermatology in Muenster with histologically proven leukocytoclastic vasculitis in files in last 10-20 years
You may qualify if:
- histologically proven leukocytoclastic vasculitis
- clinically palpable purpura
You may not qualify if:
- no histological confirmation
- relevant data missing in file
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, Univ hospital of Muenster
Münster, 48149, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cord Sunderkoetter, Prof Dr MD
Department of Dermatology, Univ Hospital of Muenster
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr
Study Record Dates
First Submitted
March 18, 2013
First Posted
March 20, 2013
Study Start
January 1, 2011
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
December 2, 2015
Record last verified: 2015-11